BlackRock Health Sciences Term Trust (NYSE:BMEZ) Sees Significant Decline in Short Interest

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 12,573 shares, a drop of 33.8% from the February 12th total of 18,985 shares. Based on an average trading volume of 218,685 shares, the short-interest ratio is currently 0.1 days. Based on an average trading volume of 218,685 shares, the short-interest ratio is currently 0.1 days.

Insider Activity

In other news, Director Robert W. Fairbairn sold 10,294 shares of the company’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds have recently made changes to their positions in the business. Kestra Advisory Services LLC purchased a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth $26,000. Geneos Wealth Management Inc. bought a new position in BlackRock Health Sciences Term Trust in the 1st quarter worth $40,000. Allworth Financial LP raised its holdings in BlackRock Health Sciences Term Trust by 24,584.6% in the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after purchasing an additional 3,196 shares in the last quarter. CWM LLC lifted its position in shares of BlackRock Health Sciences Term Trust by 25.6% in the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock worth $50,000 after purchasing an additional 680 shares during the period. Finally, Newbridge Financial Services Group Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth about $69,000.

BlackRock Health Sciences Term Trust Stock Down 1.5%

Shares of NYSE BMEZ traded down $0.21 during trading hours on Friday, hitting $13.96. The company’s stock had a trading volume of 239,647 shares, compared to its average volume of 288,493. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $15.80. The business has a 50-day simple moving average of $15.08 and a 200-day simple moving average of $14.92.

BlackRock Health Sciences Term Trust Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be given a $0.11 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 9.5%. The ex-dividend date is Monday, June 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.